Development and Validation of an Automated Image-Based Deep Learning Platform for Sarcopenia Assessment in Head and Neck Cancer
JAMA Network Open · 2023
DOI: 10.1001/jamanetworkopen.2023.28280 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, 2023. Verfasst von Zezhong Ye und 22 weiteren Autor:innen. Beteiligte Einrichtung: Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Massachusetts. Hauptthemen laut MEDLINE: Deep Learning, Sarcopenia, Head and Neck Neoplasms. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDCR NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Importance Sarcopenia is an established prognostic factor in patients with head and neck squamous cell carcinoma (HNSCC); the quantification of sarcopenia assessed by imaging is typically achieved through the skeletal muscle index (SMI), which can be derived from cervical skeletal muscle segmentation and cross-sectional area. However, manual muscle segmentation is labor intensive, prone to interobserver variability, and impractical for large-scale clinical use.
Objective
To develop and externally validate a fully automated image-based deep learning platform for cervical vertebral muscle segmentation and SMI calculation and evaluate associations with survival and treatment toxicity outcomes. Design, Setting, and Participants For this prognostic study, a model development data set was curated from publicly available and deidentified data from patients with HNSCC treated at MD Anderson Cancer Center between January 1, 2003, and December 31, 2013. A total of 899 patients undergoing primary radiation for HNSCC with abdominal computed tomography scans and complete clinical information were selected. An external validation data set was retrospectively collected from patients undergoing primary radiation therapy between January 1, 1996, and December 31, 2013, at Brigham and Women’s Hospital. The data analysis was performed between May 1, 2022, and March 31, 2023. Exposure C3 vertebral skeletal muscle segmentation during radiation therapy for HNSCC. Main Outcomes and Measures Overall survival and treatment toxicity outcomes of HNSCC.
Results
The total patient cohort comprised 899 patients with HNSCC (median [range] age, 58 [24-90] years; 140 female [15.6%] and 755 male [84.0%]). Dice similarity coefficients for the validation set (n = 96) and internal test set (n = 48) were 0.90 (95% CI, 0.90-0.91) and 0.90 (95% CI, 0.89-0.91), respectively, with a mean 96.2% acceptable rate between 2 reviewers on external clinical testing (n = 377). Estimated cross-sectional area and SMI values were associated with manually annotated values (Pearson r = 0.99; P < .001) across data sets. On multivariable Cox proportional hazards regression, SMI-derived sarcopenia was associated with worse overall survival (hazard ratio, 2.05; 95% CI, 1.04-4.04; P = .04) and longer feeding tube duration (median [range], 162 [6-1477] vs 134 [15-1255] days; hazard ratio, 0.66; 95% CI, 0.48-0.89; P = .006) than no sarcopenia. Conclusions and Relevance This prognostic study’s findings show external validation of a fully automated deep learning pipeline to accurately measure sarcopenia in HNSCC and an association with important disease outcomes. The pipeline could enable the integration of sarcopenia assessment into clinical decision making for individuals with HNSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Artificial Intelligence in Medicine Program, Mass General Brigham, Harvard Medical School, Boston, Massachusetts.
- Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
- Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Center+, Maastricht, the Netherlands.
- Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.
- Department of Data Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.
- Radiology and Nuclear Medicine, CARIM and GROW, Maastricht University, Maastricht, the Netherlands.
Förderung
- NIDCR NIH HHS
- NCI NIH HHS
Zitieren
APA
Ye, Z., Saraf, A., Ravipati, Y., Hoebers, F., Catalano, P. J., Zha, Y., Zapaishchykova, A., Likitlersuang, J., Guthier, C., Tishler, R. B., Schoenfeld, J. D., Margalit, D. N., Haddad, R. I., Mak, R. H., Naser, M., Wahid, K. A., Sahlsten, J., Jaskari, J., Kaski, K., …, & Kann, B. H. (2023). Development and Validation of an Automated Image-Based Deep Learning Platform for Sarcopenia Assessment in Head and Neck Cancer. JAMA Network Open. https://doi.org/10.1001/jamanetworkopen.2023.28280
Vancouver
Ye Z, Saraf A, Ravipati Y, Hoebers F, Catalano PJ, Zha Y, et al. Development and Validation of an Automated Image-Based Deep Learning Platform for Sarcopenia Assessment in Head and Neck Cancer. JAMA Network Open. 2023. doi:10.1001/jamanetworkopen.2023.28280
BibTeX
@article{Ye2023,
author = {Ye, Zezhong and Saraf, Anurag and Ravipati, Yashwanth and Hoebers, Frank and Catalano, Paul J and Zha, Yining and Zapaishchykova, Anna and Likitlersuang, Jirapat and Guthier, Christian and Tishler, Roy B and Schoenfeld, Jonathan D and Margalit, Danielle N and Haddad, Robert I and Mak, Raymond H and Naser, Mohamed and Wahid, Kareem A and Sahlsten, Jaakko and Jaskari, Joel and Kaski, Kimmo and Mäkitie, Antti A and Fuller, Clifton D and Aerts, Hugo J W L and Kann, Benjamin H},
title = {Development and Validation of an Automated Image-Based Deep Learning Platform for Sarcopenia Assessment in Head and Neck Cancer},
journal = {JAMA Network Open},
year = {2023},
doi = {10.1001/jamanetworkopen.2023.28280}
}
EUVIMED